PL140573B1
(en)
*
|
1982-12-21 |
1987-05-30 |
Pfizer |
Method of obtaining new dihydropyridine derivatives
|
GB8306666D0
(en)
*
|
1983-03-10 |
1983-04-13 |
Pfizer Ltd |
Therapeutic agents
|
EP0125803A3
(en)
*
|
1983-04-27 |
1987-01-21 |
FISONS plc |
Pharmaceutically active dihydropyridines
|
EP0168841B1
(en)
*
|
1983-12-19 |
1988-09-28 |
Pfizer Limited |
Dihydropyridine intermediate
|
JPS60156671A
(ja)
*
|
1984-01-25 |
1985-08-16 |
Yamanouchi Pharmaceut Co Ltd |
ジヒドロピリジン誘導体およびその製造法
|
GB8414518D0
(en)
*
|
1984-06-07 |
1984-07-11 |
Pfizer Ltd |
Therapeutic agents
|
GB8421039D0
(en)
*
|
1984-08-17 |
1984-09-19 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
GR851819B
(sv)
*
|
1984-08-17 |
1985-11-26 |
Wyeth John & Brother Ltd |
|
IL77843A
(en)
*
|
1985-02-11 |
1989-07-31 |
Syntex Inc |
Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them
|
EP0200524A3
(en)
*
|
1985-05-03 |
1987-06-16 |
Pfizer Limited |
Dihydropyridine calcium antagonists
|
DE3531498A1
(de)
*
|
1985-09-04 |
1987-03-05 |
Bayer Ag |
Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
|
EP0225175A3
(en)
*
|
1985-11-28 |
1988-12-28 |
FISONS plc |
Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
|
DE3544211A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
IT1204460B
(it)
*
|
1986-02-20 |
1989-03-01 |
Glaxo Spa |
Derivati eterociclici
|
GB8608335D0
(en)
*
|
1986-04-04 |
1986-05-08 |
Pfizer Ltd |
Pharmaceutically acceptable salts
|
US4983740A
(en)
*
|
1986-08-04 |
1991-01-08 |
Adir Et Compagnie |
Process for 1,4-dihydropyridine compounds
|
FR2602231B1
(fr)
*
|
1986-08-04 |
1988-10-28 |
Adir |
Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
|
FR2649395B1
(fr)
*
|
1989-07-04 |
1992-11-06 |
Adir |
Nouveau derive de la dihydro-1,4 pyridine denomme (-) i1(((amino-2 ethoxy)-2 ethoxy) methyli1) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
IT1213555B
(it)
*
|
1986-12-11 |
1989-12-20 |
Boehringer Biochemia Srl |
2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
|
JPS63196564A
(ja)
*
|
1987-02-10 |
1988-08-15 |
Agency Of Ind Science & Technol |
イミドオリゴマ−の製造方法
|
IT1215381B
(it)
*
|
1987-03-12 |
1990-02-08 |
Boehringer Biochemia Srl |
Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni
|
GB8709447D0
(en)
*
|
1987-04-21 |
1987-05-28 |
Pfizer Ltd |
Dihydropyridines
|
GB8710493D0
(en)
*
|
1987-05-02 |
1987-06-03 |
Pfizer Ltd |
Dihydropyridines
|
DE3906406C1
(sv)
*
|
1989-03-01 |
1990-10-25 |
Goedecke Ag, 1000 Berlin, De |
|
DE4128132A1
(de)
*
|
1991-08-24 |
1993-02-25 |
Bayer Ag |
3-(2-chlor-3-trifluormethylphenyl)-4-cyanopyrrol, dessen herstellung und verwendung und neue zwischenprodukte
|
US5234943A
(en)
*
|
1989-04-13 |
1993-08-10 |
Bayer Aktiengesellschaft |
Fungicidal 3-(2-chloro-3-trifluoromethylphenyl)-4-cyanopyrrole
|
FR2652083B1
(fr)
*
|
1989-09-20 |
1992-01-24 |
Ador Cie |
Nouveau procede de separation d'isomeres optiques des derives de la dihydro-1,4 pyridine.
|
US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
CA2124445A1
(en)
*
|
1991-11-26 |
1993-06-10 |
James W. Young |
Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
EP1614420A3
(en)
*
|
1992-11-25 |
2006-04-19 |
Sepracor Inc. |
Treatment of hypertension, angina and other disorders using (-) amlodipine
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
JPH11500140A
(ja)
|
1995-03-16 |
1999-01-06 |
ファイザー・インコーポレーテッド |
アムロジピン、アムロジピン塩、もしくはフェロジピンとace阻害薬とを含有する組成物
|
NZ280378A
(en)
*
|
1995-11-01 |
1998-04-27 |
Apotex Inc |
4-phenyl-1,4-dihydropyridine-3,5-dicarboxylic acid compounds, preparation, intermediate compounds
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
ZA9810319B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
|
ZA9810320B
(en)
*
|
1997-11-14 |
2000-05-11 |
Gea Farmaceutisk Fabrik As |
Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
|
ES2151850B1
(es)
*
|
1998-10-26 |
2001-08-16 |
Esteve Quimica Sa |
Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
JP2003500487A
(ja)
|
1999-05-27 |
2003-01-07 |
ファイザー・プロダクツ・インク |
アムロジピンおよびアトルバスタチンの共通プロドラッグ
|
UA72768C2
(en)
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
CN1091441C
(zh)
*
|
1999-12-04 |
2002-09-25 |
昆明赛诺制药有限公司 |
甲磺酸氨氯地平及其制法和应用
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
KR100756565B1
(ko)
*
|
2000-04-11 |
2007-09-07 |
상꾜 가부시키가이샤 |
칼슘 채널 블록커를 함유하는 안정화된 약제 조성물
|
WO2002017913A1
(fr)
*
|
2000-08-30 |
2002-03-07 |
Sankyo Company, Limited |
Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
AU2001294354A1
(en)
*
|
2000-12-29 |
2002-07-16 |
Bioorganics B.V. |
Process for making amlodipine, derivatives thereof, and precursors therefor
|
WO2002053538A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Amlodipine fumarate
|
GB2371862B
(en)
*
|
2000-12-29 |
2004-07-14 |
Bioorg Bv |
Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
|
US6653481B2
(en)
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
BR0116552A
(pt)
|
2000-12-29 |
2004-02-03 |
Pfizer Ltd |
Hemi-maleato de amlodipina, processo, método para o tratamento ou prevenção de angina ou hipertensão, composição farmacêutica, para uso no tratamento e/ou de angina ou da hipertensão
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
MXPA03005886A
(es)
*
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado de aspartato de amlodipina como antagonista del canal de calcio.
|
WO2002053541A1
(en)
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Amide derivative of amlodipine
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
WO2002053542A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Process for making amlodipine maleate
|
GEP20063946B
(en)
*
|
2000-12-29 |
2006-10-25 |
Pfizer Ltd |
Process for making amlodipine maleate
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
KR100374767B1
(ko)
*
|
2001-03-13 |
2003-03-03 |
한미약품공업 주식회사 |
개선된 암로디핀의 제조 방법
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
EP1435954B1
(en)
*
|
2001-07-06 |
2010-01-13 |
LEK Pharmaceuticals D.D. |
A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE
|
GB0120808D0
(en)
*
|
2001-08-28 |
2001-10-17 |
Pfizer Ltd |
Crystalline material
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
US20030180354A1
(en)
*
|
2001-10-17 |
2003-09-25 |
Dr. Reddy's Laboratories Limited |
Amlodipine maleate formulations
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
US6562983B1
(en)
*
|
2002-03-18 |
2003-05-13 |
Council Of Scientific And Industrial Research |
Process for the preparation of alkyl 4[2-(phthalimido)ethoxy]-acetoacetate
|
EP1499592A4
(en)
*
|
2002-04-13 |
2010-01-13 |
Hanlim Pharmaceutical Co Ltd |
AMLODIPINE NICOTINATE AND PROCESS FOR PREPARING THE SAME
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100496436B1
(ko)
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100538641B1
(ko)
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
MXPA05001958A
(es)
|
2002-08-19 |
2005-04-28 |
Pfizer Prod Inc |
Terapia de combinacion para enfermedades hiperproliferativas.
|
KR100467669B1
(ko)
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
AU2003260984A1
(en)
|
2002-09-11 |
2004-04-30 |
Hanlim Pharmaceutical Co., Ltd. |
S-(-)-amlodipine nicotinate and process for the preparation thereof
|
AU2003253460A1
(en)
|
2002-09-19 |
2004-04-08 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
KR100596369B1
(ko)
|
2002-09-19 |
2006-07-03 |
씨제이 주식회사 |
결정형의 암로디핀 유기산염
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
WO2004058711A1
(en)
*
|
2002-12-30 |
2004-07-15 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
DE10335027A1
(de)
*
|
2003-07-31 |
2005-02-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verwendung von Angiotensin II Rezeptor Antagonisten
|
AU2004208615C1
(en)
*
|
2003-01-31 |
2010-05-13 |
Daiichi Sankyo Company, Limited |
Medicine for prevention of and treatment for arteriosclerosis and hypertension
|
US20050019395A1
(en)
*
|
2003-04-14 |
2005-01-27 |
Gabor Pragai |
Formulations of amlodipine maleate
|
WO2004093813A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
|
WO2004093816A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Pharmacia Corporation |
Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
|
WO2004096770A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Cipla Limited |
Process for preparing almodipine mesylate monohydrate
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
AU2004247627A1
(en)
*
|
2003-05-16 |
2004-12-23 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
EA009646B1
(ru)
*
|
2003-05-30 |
2008-02-28 |
Рэнбакси Лабораториз Лтд. |
Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
|
GB2419529B
(en)
*
|
2003-07-17 |
2008-01-09 |
Cotherix Inc |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
US20050037063A1
(en)
*
|
2003-07-21 |
2005-02-17 |
Bolton Anthony E. |
Combined therapies
|
CH697952B1
(de)
*
|
2003-07-25 |
2009-03-31 |
Siegfried Generics Int Ag |
Verfahren zur Reinigung der freien Amlodipinbase.
|
WO2005023769A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Cipla Limited |
Process for the preparation of amlodipine salts
|
AU2004272078A1
(en)
*
|
2003-09-10 |
2005-03-24 |
Synta Pharmaceuticals Corp. |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
KR100841409B1
(ko)
*
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US20060030602A1
(en)
*
|
2004-03-16 |
2006-02-09 |
Sepracor Inc. |
(S)-amlodipine malate
|
US7244765B2
(en)
*
|
2004-06-25 |
2007-07-17 |
Cytokine Pharmasciences, Inc |
Guanylhydrazone salts, compositions, processes of making and methods of using
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2006003672A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Matrix Laboratories Ltd |
Process for the preparation of pure amlodipine
|
CN101090714A
(zh)
*
|
2004-07-26 |
2007-12-19 |
康泽里克斯公司 |
通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症
|
DK1814527T4
(da)
*
|
2004-11-05 |
2020-12-07 |
Boehringer Ingelheim Int |
Dobbeltlagstablet omfattende telmisartan og amlodipin
|
MX2007005137A
(es)
*
|
2004-11-23 |
2007-06-22 |
Warner Lambert Co |
Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
|
WO2006070248A1
(en)
*
|
2004-12-28 |
2006-07-06 |
Ranbaxy Laboratories Limited |
Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
|
WO2006085208A2
(en)
*
|
2005-02-11 |
2006-08-17 |
Ranbaxy Laboratories Limited |
Stable solid dosage forms of amlodipine and benazepril
|
KR20130135994A
(ko)
*
|
2005-06-27 |
2013-12-11 |
다이이찌 산쿄 가부시키가이샤 |
안지오텐신 ⅱ 수용체 길항제 및 칼슘 채널 차단제를 함유한 약학 제제
|
EP1898922A4
(en)
*
|
2005-07-04 |
2012-03-14 |
Ramu Krishnan |
MEDICINE OR IMPROVED PHARMACEUTICAL COMPOUNDS AND PREPARATION THEREOF
|
ES2265781B1
(es)
*
|
2005-08-04 |
2007-12-01 |
Ercros Industrial, S.A. |
Procedimiento para la obtencion de besilato de amlodipina.
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
EP2351569B1
(en)
|
2005-10-26 |
2012-08-22 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
ATE551059T1
(de)
|
2005-10-26 |
2012-04-15 |
Asahi Kasei Pharma Corp |
Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
|
AU2006313430B2
(en)
*
|
2005-11-08 |
2012-09-06 |
Ranbaxy Laboratories Limited |
Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
TW200806648A
(en)
*
|
2005-11-29 |
2008-02-01 |
Sankyo Co |
Acid addition salts of dihydropyridine derivatives
|
TW200736245A
(en)
*
|
2005-11-29 |
2007-10-01 |
Sankyo Co |
Acid addition salts of optically active dihydropyridine derivatives
|
US7919506B2
(en)
|
2006-03-10 |
2011-04-05 |
Pfizer Inc. |
Dibenzyl amine compounds and derivatives
|
TW200744583A
(en)
*
|
2006-03-14 |
2007-12-16 |
Ranbaxy Lab Ltd |
Statin stabilizing dosage formulations
|
US20070260065A1
(en)
*
|
2006-05-03 |
2007-11-08 |
Vijayabhaskar Bolugoddu |
Process for preparing amlodipine
|
MX2009000439A
(es)
*
|
2006-07-14 |
2009-02-04 |
Ranbaxy Lab Ltd |
Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
|
WO2008023869A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Hanall Pharmaceutical Co., Ltd. |
Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors
|
TWI399223B
(zh)
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
KR100830003B1
(ko)
|
2006-10-31 |
2008-05-15 |
씨제이제일제당 (주) |
결정성 s-(-)-암로디핀 아디핀산 염 무수물 및 이의 제조방법
|
GB0624087D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril combination salt
|
GB0624090D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amine salts
|
GB0624084D0
(en)
*
|
2006-12-01 |
2007-01-10 |
Selamine Ltd |
Ramipril amino acid salts
|
CN101663262B
(zh)
|
2006-12-01 |
2014-03-26 |
百时美施贵宝公司 |
用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
|
TWI384986B
(zh)
*
|
2007-01-17 |
2013-02-11 |
Lg Life Sciences Ltd |
抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
|
CN101230035B
(zh)
*
|
2007-03-23 |
2010-11-03 |
浙江尖峰药业有限公司 |
门冬氨酸氨氯地平系列盐及其制备方法和其组合物、制剂以及片剂
|
EP1975167A1
(en)
*
|
2007-03-30 |
2008-10-01 |
Esteve Quimica, S.A. |
Acetone solvate of phthaloyl amlodipine
|
WO2008124121A1
(en)
*
|
2007-04-06 |
2008-10-16 |
Scidose, Llc |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
US20090062352A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched amlodipine
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
PE20091156A1
(es)
*
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
MX2010007281A
(es)
*
|
2007-12-31 |
2010-10-05 |
Lupin Ltd |
Composiciones farmaceuticas de amlodipina y valsartan.
|
ES2510866T3
(es)
*
|
2008-03-13 |
2014-10-21 |
Daiichi Sankyo Company, Limited |
Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
|
CN101560181B
(zh)
*
|
2008-04-16 |
2013-02-27 |
北京万全阳光医学技术有限公司 |
一种氨氯地平游离碱的制备方法
|
CN101367759B
(zh)
*
|
2008-10-06 |
2011-03-16 |
北京赛科药业有限责任公司 |
一种高纯度苯磺酸氨氯地平的合成方法
|
JP2010100562A
(ja)
*
|
2008-10-23 |
2010-05-06 |
Daito Kk |
アムロジピン製造中間体の精製方法
|
US8956654B2
(en)
|
2009-06-02 |
2015-02-17 |
Dow Global Technologies Llc |
Sustained release dosage form
|
JP5815552B2
(ja)
|
2009-12-08 |
2015-11-17 |
ケース ウェスタン リザーブ ユニバーシティCase Westernreserve University |
眼疾患を治療する化合物および方法
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
IT1400309B1
(it)
*
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
EP2575808A1
(en)
|
2010-05-28 |
2013-04-10 |
Mahmut Bilgic |
Combination of antihypertensive agents
|
EP2575757A1
(en)
|
2010-06-03 |
2013-04-10 |
Mahmut Bilgic |
Water soluble formulation comprising a combination of amlodipine and a statin
|
WO2012037665A1
(en)
|
2010-09-24 |
2012-03-29 |
Oral Delivery Technology Ltd. |
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
|
EA025946B1
(ru)
|
2010-10-27 |
2017-02-28 |
Крка, Товарна Здравил, Д. Д., Ново Место |
Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
|
TR201100152A2
(tr)
|
2011-01-06 |
2012-07-23 |
Bi̇lgi̇ç Mahmut |
Amlodipin içeren efervesan bileşimler.
|
CN102070516A
(zh)
*
|
2011-02-22 |
2011-05-25 |
广东东阳光药业有限公司 |
一种制备氨氯地平的方法
|
WO2012123966A1
(en)
|
2011-03-04 |
2012-09-20 |
Arch Pharmalabs Limited |
Process for the preparation of 4 -substituted -1, 4-dihydropyridines
|
EA024096B1
(ru)
|
2011-04-12 |
2016-08-31 |
Борюн Фармасьютикал Ко., Лтд. |
Противогипертоническая фармацевтическая композиция
|
MX2014002163A
(es)
|
2011-08-26 |
2014-09-25 |
Wockhardt Ltd |
Métodos para el tratamiento de desórdenes cardiovasculares.
|
CN102382041B
(zh)
*
|
2011-12-02 |
2016-01-20 |
东北制药集团股份有限公司 |
一种马来酸氨氯地平的制备方法
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
CN103044314A
(zh)
*
|
2013-01-06 |
2013-04-17 |
先声药业有限公司 |
马来酸氨氯地平的制备方法
|
JP5952748B2
(ja)
*
|
2013-01-25 |
2016-07-13 |
東和薬品株式会社 |
フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法
|
WO2014122585A1
(en)
|
2013-02-08 |
2014-08-14 |
Wockhardt Limited |
A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
|
CN105143203A
(zh)
|
2013-04-17 |
2015-12-09 |
辉瑞大药厂 |
用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
|
ES2847904T3
(es)
|
2013-07-23 |
2021-08-04 |
Daiichi Sankyo Co Ltd |
Medicamento para la prevención o el tratamiento de la hipertensión
|
CN104262237A
(zh)
*
|
2014-09-28 |
2015-01-07 |
常州瑞明药业有限公司 |
氨氯地平自由碱的合成方法
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
CZ2015687A3
(cs)
|
2015-10-02 |
2017-04-12 |
Zentiva, K.S. |
Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
|
US20180303811A1
(en)
|
2015-10-23 |
2018-10-25 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
EP3434284A4
(en)
|
2016-03-24 |
2019-11-13 |
Daiichi Sankyo Company, Limited |
MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
|
JP6411662B2
(ja)
|
2016-05-30 |
2018-10-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
固定容量配合剤
|
EP3960158A1
(en)
|
2016-10-07 |
2022-03-02 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
US10799453B2
(en)
|
2018-04-11 |
2020-10-13 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
JP7470646B2
(ja)
|
2018-06-14 |
2024-04-18 |
アストラゼネカ・ユーケイ・リミテッド |
コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
|
US11417416B2
(en)
*
|
2018-06-14 |
2022-08-16 |
Astrazeneca Uk Limited |
Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
|
CN113574055B
(zh)
|
2019-01-18 |
2024-07-23 |
阿斯利康(瑞典)有限公司 |
Pcsk9抑制剂及其使用方法
|
JP2022533316A
(ja)
|
2019-05-21 |
2022-07-22 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
食品用ブチレート
|
GB2595203A
(en)
|
2020-03-03 |
2021-11-24 |
Alkaloid Ad Skopje |
Formulation
|
GB202102575D0
(en)
|
2021-02-23 |
2021-04-07 |
Teva Pharmaceutical Industries Ltd |
Fixed-dose pharmaceutical compositions
|